NAV3 Is a Novel Prognostic Biomarker Affecting the Immune Status of the Tumor Microenvironment in Colorectal Cancer

Figure 2

Relationship of scores showing clinicopathological staging features: (a–c) ImmuneScore in gender, age, and stage; (d–f) StromalScores in gender, age, and stage; (g–i) ESTIMATEScores in gender, age, and stage.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)